Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic #
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic #
Creator
Chew, Derek
Devlin, Gerard
Brieger, David
Cullen, Louise
Dwyer, Nathan
Hillis, Graham
Kerr, Andrew
Lo, Sidney
Nasis, Arthur
Parsonage, William
Than, Martin
Wahi, Sudhur
Source
Elsevier; Medline; PMC
abstract
Abstract A pandemic of Coronavirus-19 disease was declared by the World Health Organization on March 11, 2020. The pandemic is expected to place unprecedented demand on health service delivery. This position statement has been developed by the Cardiac Society of Australia and New Zealand to assist clinicians to continue to deliver rapid and safe evaluation of patients presenting with suspected acute cardiac syndrome at this time. The position statement complements, and should be read in conjunction with, the National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016: Section 2 ‘Assessment of Possible Cardiac Chest Pain’.
has issue date
2020-05-21
(
xsd:dateTime
)
bibo:doi
10.1016/j.hlc.2020.05.003
bibo:pmid
32601022
has license
els-covid
sha1sum (hex)
fad7482b7b2b4314ba7fe65b4d17e2747a714ae7
schema:url
https://doi.org/10.1016/j.hlc.2020.05.003
resource representing a document's title
CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic #
has PubMed Central identifier
PMC7241352
has PubMed identifier
32601022
schema:publication
Heart Lung Circ
resource representing a document's body
covid:fad7482b7b2b4314ba7fe65b4d17e2747a714ae7#body_text
is
schema:about
of
named entity 'COVID-19'
named entity 'Coronary'
named entity 'acute coronary syndromes'
named entity 'influenza-like illness'
named entity 'COVID-19 pandemic'
named entity 'emergency departments'
named entity 'ischaemia'
named entity 'chest pain'
named entity 'ACS'
named entity 'New Zealand'
named entity 'fully informed'
named entity 'serum'
named entity 'ECG'
named entity 'evidence-based'
named entity 'coronary artery disease'
named entity 'coronary artery disease'
named entity 'revascularisation'
named entity 'short-term'
named entity 'ACS'
named entity 'ACS'
named entity 'troponin'
named entity 'cTnT'
named entity 'coronary artery disease'
named entity 'Anecdotal evidence'
named entity 'chest pain'
named entity 'COVID-19'
named entity 'chest pain'
named entity 'chest pain'
named entity 'ACS'
named entity 'coronary artery disease'
named entity 'ILI'
named entity 'chest pain'
named entity 'follow-up'
named entity 'aetiologies'
named entity 'telehealth'
named entity 'emergency department'
named entity 'risk stratification'
named entity 'acute myocardial injury'
named entity 'evidence-based approaches'
named entity 'serum'
named entity 'troponin'
named entity 'New Zealand'
named entity 'risk stratification'
named entity 'coronary artery disease'
named entity 'chest pain'
named entity 'primary care'
named entity 'clinical features'
named entity 'AMI'
named entity 'troponin'
named entity 'Abbott Laboratories'
named entity 'acute myocardial infarction'
named entity 'troponin'
named entity 'troponin'
named entity 'ILI'
named entity 'Clinical Guidelines'
named entity 'coronary artery disease'
named entity 'health services'
named entity 'patient safety'
named entity 'reference range'
named entity 'AMI'
named entity 'troponin'
named entity 'troponin'
named entity 'telehealth'
named entity 'health services'
named entity 'serum'
named entity 'COVID-19 pandemic'
named entity 'ACS'
named entity 'ACS'
named entity 'Clinical Guidelines'
named entity 'COVID-19'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 3
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software